Rhythm Pharmaceuticals IncRYTM
Price$93.41Intrinsic value$103.6411% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $103.64median of 2 methodsbased on filings through 30 Jun 2026
Market Price $93.41Price as of 1 Oct 2026
Margin of Safety +11.0%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Discount rate (cost of equity) 12.4%
Volatility vs market (adjusted beta)1.65

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetRhythm Pharmaceuticals IncRYTMHealth Care
Valuation
P/E—
P/S28.4×
P/B67.2×
EV / Revenue28.6×
EV / EBITDA-33.0×
Profitability
Gross margin87.4%
Operating margin-98.6%
Net margin-85.6%
FCF margin-44.3%
Returns
ROE-199.4%
ROA-47.0%
ROIC—
Growth
Revenue growth (YoY)84.4%
5-yr fwd EPS growth—
Financial strength
Debt / Equity1.03×
Current ratio3.45×
Altman Z-Score13.9
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.